Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) studyPierre‐François Laterre, Oliver Hartmann, P. Scigalla et al.|Critical Care|2018Cited by 134
Dose-Related Effects of Recombinant Human Erythropoietin on ErythropoiesisJ. Bömmer, P. Scigalla, Markus Kügel et al.|Contributions to nephrology|2015Cited by 63
Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.J. Bömmer, P. Scigalla, Markus Kügel et al.|PubMed|1988Cited by 55
A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)Christopher Geven, Peter Pickkers, Alice Blet et al.|BMJ Open|2019Cited by 48